{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:17:58Z","timestamp":1787883478897,"version":"build-2784847793"},"reference-count":204,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"DOI":"10.1038\/s41577-026-01344-9","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:56:42Z","timestamp":1787839002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetic regulation of B cell tolerance and dysfunction in autoimmune disease"],"prefix":"10.1038","author":[{"given":"Shaocun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0395-2800","authenticated-orcid":false,"given":"Wanli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"1344_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41586-019-0879-y","volume":"566","author":"B Briney","year":"2019","unstructured":"Briney, B., Inderbitzin, A., Joyce, C. & Burton, D. R. Commonality despite exceptional diversity in the baseline human antibody repertoire. Nature 566, 393\u2013397 (2019).","journal-title":"Nature"},{"key":"1344_CR2","unstructured":"Tonegawa, S. Somatic generation of immune diversity. Nobel Prize Lecture. The Nobel Prize https:\/\/www.nobelprize.org\/prizes\/medicine\/1987\/tonegawa\/lecture\/ (1987)."},{"key":"1344_CR3","unstructured":"Murphy, K. M. W. C. Janeway\u2019s Immunobiology 9th edn (Garland Science, 2017)."},{"key":"1344_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nri3804","volume":"15","author":"NS De Silva","year":"2015","unstructured":"De Silva, N. S. & Klein, U. Dynamics of B cells in germinal centres. Nat. Rev. Immunol. 15, 137\u2013148 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"1344_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41577-019-0244-2","volume":"20","author":"M Akkaya","year":"2020","unstructured":"Akkaya, M., Kwak, K. & Pierce, S. K. B cell memory: building two walls of protection against pathogens. Nat. Rev. Immunol. 20, 229\u2013238 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1344_CR6","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1126\/science.1086907","volume":"301","author":"H Wardemann","year":"2003","unstructured":"Wardemann, H. et al. Predominant autoantibody production by early human B cell precursors. Science 301, 1374\u20131377 (2003). This landmark study demonstrates that most early human B cell precursors produce autoreactive antibodies, establishing that central tolerance mechanisms must eliminate a large proportion of the initial B cell repertoire.","journal-title":"Science"},{"key":"1344_CR7","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/ni1076","volume":"5","author":"R Halverson","year":"2004","unstructured":"Halverson, R., Torres, R. M. & Pelanda, R. Receptor editing is the main mechanism of B cell tolerance toward membrane antigens. Nat. Immunol. 5, 645\u2013650 (2004).","journal-title":"Nat. Immunol."},{"key":"1344_CR8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/1074-7613(95)90059-4","volume":"3","author":"JG Cyster","year":"1995","unstructured":"Cyster, J. G. & Goodnow, C. C. Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity 3, 691\u2013701 (1995).","journal-title":"Immunity"},{"key":"1344_CR9","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.immuni.2006.10.017","volume":"25","author":"KT Merrell","year":"2006","unstructured":"Merrell, K. T. et al. Identification of anergic B cells within a wild-type repertoire. Immunity 25, 953\u2013962 (2006).","journal-title":"Immunity"},{"key":"1344_CR10","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nm.2425","volume":"17","author":"MA Linterman","year":"2011","unstructured":"Linterman, M. A. et al. Foxp3+ follicular regulatory T cells control the germinal center response. Nat. Med. 17, 975\u2013982 (2011).","journal-title":"Nat. Med."},{"key":"1344_CR11","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.celrep.2015.08.036","volume":"12","author":"PM Dominguez","year":"2015","unstructured":"Dominguez, P. M. et al. DNA methylation dynamics of germinal center B cells are mediated by AID. Cell Rep. 12, 2086\u20132098 (2015).","journal-title":"Cell Rep."},{"key":"1344_CR12","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41590-023-01721-9","volume":"25","author":"D Callahan","year":"2024","unstructured":"Callahan, D. et al. Memory B cell subsets have divergent developmental origins that are coupled to distinct imprinted epigenetic states. Nat. Immunol. 25, 562\u2013575 (2024).","journal-title":"Nat. Immunol."},{"key":"1344_CR13","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2016.02.021","volume":"44","author":"S Boller","year":"2016","unstructured":"Boller, S. et al. Pioneering activity of the C-terminal domain of EBF1 shapes the chromatin landscape for B cell programming. Immunity 44, 527\u2013541 (2016).","journal-title":"Immunity"},{"key":"1344_CR14","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1170116","volume":"324","author":"M Tahiliani","year":"2009","unstructured":"Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930\u2013935 (2009).","journal-title":"Science"},{"key":"1344_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature14192","volume":"517","author":"D Schubeler","year":"2015","unstructured":"Schubeler, D. Function and information content of DNA methylation. Nature 517, 321\u2013326 (2015).","journal-title":"Nature"},{"key":"1344_CR16","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41576-022-00468-7","volume":"23","author":"G Mill\u00e1n-Zambrano","year":"2022","unstructured":"Mill\u00e1n-Zambrano, G., Burton, A., Bannister, A. J. & Schneider, R. Histone post-translational modifications\u2014cause and consequence of genome function. Nat. Rev. Genet. 23, 563\u2013580 (2022).","journal-title":"Nat. Rev. Genet."},{"key":"1344_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrm.2017.94","volume":"19","author":"DV Fyodorov","year":"2018","unstructured":"Fyodorov, D. V., Zhou, B. R., Skoultchi, A. I. & Bai, Y. Emerging roles of linker histones in regulating chromatin structure and function. Nat. Rev. Mol. Cell Biol. 19, 192\u2013206 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1344_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41580-023-00683-y","volume":"25","author":"S Eustermann","year":"2024","unstructured":"Eustermann, S., Patel, A. B., Hopfner, K. P., He, Y. & Korber, P. Energy-driven genome regulation by ATP-dependent chromatin remodellers. Nat. Rev. Mol. Cell Biol. 25, 309\u2013332 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1344_CR19","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41573-024-00978-5","volume":"23","author":"HA Malone","year":"2024","unstructured":"Malone, H. A. & Roberts, C. W. M. Chromatin remodellers as therapeutic targets. Nat. Rev. Drug Discov. 23, 661\u2013681 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1344_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nmeth.4110","volume":"14","author":"X Li","year":"2016","unstructured":"Li, X., Xiong, X. & Yi, C. Epitranscriptome sequencing technologies: decoding RNA modifications. Nat. Methods 14, 23\u201331 (2016).","journal-title":"Nat. Methods"},{"key":"1344_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41573-025-01280-8","volume":"25","author":"L Zhang","year":"2025","unstructured":"Zhang, L., Wei, J., Zou, Z. & He, C. RNA modification systems as therapeutic targets. Nat. Rev. Drug Discov. 25, 59\u201378 (2025).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1344_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08679-z","volume":"10","author":"X Agirre","year":"2019","unstructured":"Agirre, X. et al. Long non-coding RNAs discriminate the stages and gene regulatory states of human humoral immune response. Nat. Commun. 10, 821 (2019).","journal-title":"Nat. Commun."},{"key":"1344_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena, L., Poliseno, L., Tay, Y., Kats, L. & Pandolfi, P. P. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146, 353\u2013358 (2011).","journal-title":"Cell"},{"key":"1344_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","volume":"173","author":"DP Bartel","year":"2018","unstructured":"Bartel, D. P. Metazoan microRNAs. Cell 173, 20\u201351 (2018).","journal-title":"Cell"},{"key":"1344_CR25","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1111\/febs.14934","volume":"286","author":"K Schoeler","year":"2019","unstructured":"Schoeler, K. et al. TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells. FEBS J. 286, 3566\u20133581 (2019).","journal-title":"FEBS J."},{"key":"1344_CR26","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.18290","volume":"5","author":"CW Lio","year":"2016","unstructured":"Lio, C. W. et al. Tet2 and Tet3 cooperate with B-lineage transcription factors to regulate DNA modification and chromatin accessibility. eLife 5, e18290 (2016).","journal-title":"eLife"},{"key":"1344_CR27","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/nature06431","volume":"450","author":"AGW Matthews","year":"2007","unstructured":"Matthews, A. G. W. et al. RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination. Nature 450, 1106\u20131110 (2007). This study reveals that the non-canonical PHD finger domain of RAG2 specifically recognizes H3K4me3, providing the first mechanistic link between a histone modification and the enzymatic machinery of V(D)J recombination.","journal-title":"Nature"},{"key":"1344_CR28","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ccr.2013.04.011","volume":"23","author":"W B\u00e9guelin","year":"2013","unstructured":"B\u00e9guelin, W. et al. EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell 23, 677\u2013692 (2013).","journal-title":"Cancer Cell"},{"key":"1344_CR29","doi-asserted-by":"publisher","first-page":"246ra299","DOI":"10.1126\/scitranslmed.3009131","volume":"6","author":"XN Wu","year":"2014","unstructured":"Wu, X. N. et al. Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus. Sci. Transl. Med. 6, 246ra299 (2014).","journal-title":"Sci. Transl. Med."},{"key":"1344_CR30","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.123384","volume":"4","author":"MJ Smith","year":"2019","unstructured":"Smith, M. J. et al. Elevated PTEN expression maintains anergy in human B cells and reveals unexpectedly high repertoire autoreactivity. JCI Insight 4, e123384 (2019).","journal-title":"JCI Insight"},{"key":"1344_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/ni.3385","volume":"17","author":"A Gonzalez-Martin","year":"2016","unstructured":"Gonzalez-Martin, A. et al. The microRNA miR-148a functions as a critical regulator of B cell tolerance and autoimmunity. Nat. Immunol. 17, 433\u2013440 (2016). This study shows that miR-148a suppresses the autoimmune suppressor GADD45\u03b1, the tumour suppressor PTEN and the pro-apoptotic protein BIM to allow survival of immature B cells after autoreactive BCR engagement. Elevated miR-148a is frequently observed in patients with SLE and lupus-prone mice.","journal-title":"Nat. Immunol."},{"key":"1344_CR32","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1016\/j.cell.2021.02.015","volume":"184","author":"B Yu","year":"2021","unstructured":"Yu, B. et al. B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells. Cell 184, 1790\u20131803.e17 (2021). This study identifies a B cell-specific XIST RNA\u2013protein complex that maintains X-chromosome inactivation in mature B cells. Loss of this complex licences expansion of atypical B cells and provides a B cell-intrinsic epigenetic mechanism linking X-chromosome dosage control to the female bias of systemic autoimmunity.","journal-title":"Cell"},{"key":"1344_CR33","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1016\/j.immuni.2024.10.004","volume":"57","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Progressive polyadenylation and m6A modification of Ighg1 mRNA maintain IgG1 antibody homeostasis in antibody-secreting cells. Immunity 57, 2547\u20132564.e12 (2024).","journal-title":"Immunity"},{"key":"1344_CR34","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41590-020-0700-y","volume":"21","author":"S Tanaka","year":"2020","unstructured":"Tanaka, S. et al. Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity. Nat. Immunol. 21, 950\u2013961 (2020). Together with Lio et al. (2016), this study demonstrates that TET2 and TET3 enforce peripheral B cell anergy through TET-dependent demethylation and recruitment of HDAC1 and HDAC2 to suppress Cd86 expression and prevent spontaneous autoimmunity.","journal-title":"Nat. Immunol."},{"key":"1344_CR35","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s41590-019-0419-9","volume":"20","author":"CD Scharer","year":"2019","unstructured":"Scharer, C. D. et al. Epigenetic programming underpins B cell dysfunction in human SLE. Nat. Immunol. 20, 1071\u20131082 (2019). This study establishes that disease-specific chromatin accessibility alterations and DNA methylation defects are pre-established in resting naive SLE B cells prior to activation, and persist throughout the differentiation trajectory.","journal-title":"Nat. Immunol."},{"key":"1344_CR36","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","volume":"49","author":"SA Jenks","year":"2018","unstructured":"Jenks, S. A. et al. Distinct effector B cells induced by unregulated Toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity 49, 725\u2013739.e6 (2018).","journal-title":"Immunity"},{"key":"1344_CR37","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1136\/annrheumdis-2015-208659","volume":"75","author":"J Imgenberg-Kreuz","year":"2016","unstructured":"Imgenberg-Kreuz, J. et al. Genome-wide DNA methylation analysis in multiple tissues in primary Sj\u00f6gren\u2019s syndrome reveals regulatory effects at interferon-induced genes. Ann. Rheum. Dis. 75, 2029\u20132036 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"1344_CR38","doi-asserted-by":"publisher","first-page":"103341","DOI":"10.1016\/j.jaut.2024.103341","volume":"149","author":"Y Yang","year":"2024","unstructured":"Yang, Y. et al. EZH2 promotes B-cell autoimmunity in primary Sjogren\u2019s syndrome via METTL3-mediated m6A modification. J. Autoimmun. 149, 103341 (2024).","journal-title":"J. Autoimmun."},{"key":"1344_CR39","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s42003-023-04713-5","volume":"6","author":"Q Ma","year":"2023","unstructured":"Ma, Q. et al. Integration of epigenetic and genetic profiles identifies multiple sclerosis disease-critical cell types and genes. Commun. Biol. 6, 342 (2023).","journal-title":"Commun. Biol."},{"key":"1344_CR40","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","volume":"12","author":"GC Tsokos","year":"2016","unstructured":"Tsokos, G. C., Lo, M. S., Costa Reis, P. & Sullivan, K. E. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat. Rev. Rheum. 12, 716\u2013730 (2016).","journal-title":"Nat. Rev. Rheum."},{"key":"1344_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cell.2007.06.033","volume":"130","author":"CC Goodnow","year":"2007","unstructured":"Goodnow, C. C. Multistep pathogenesis of autoimmune disease. Cell 130, 25\u201335 (2007).","journal-title":"Cell"},{"key":"1344_CR42","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/ni.3731","volume":"18","author":"AN Theofilopoulos","year":"2017","unstructured":"Theofilopoulos, A. N., Kono, D. H. & Baccala, R. The multiple pathways to autoimmunity. Nat. Immunol. 18, 716\u20137241 (2017).","journal-title":"Nat. Immunol."},{"key":"1344_CR43","doi-asserted-by":"publisher","first-page":"11258","DOI":"10.1073\/pnas.0809485106","volume":"106","author":"H Gao","year":"2009","unstructured":"Gao, H. et al. Opposing effects of SWI\/SNF and Mi-2\/NuRD chromatin remodeling complexes on epigenetic reprogramming by EBF and Pax5. Proc. Natl Acad. Sci. USA 106, 11258\u201311263 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1344_CR44","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.immuni.2010.04.013","volume":"32","author":"T Treiber","year":"2010","unstructured":"Treiber, T. et al. Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription-independent poising of chromatin. Immunity 32, 714\u2013725 (2010).","journal-title":"Immunity"},{"key":"1344_CR45","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/ni876","volume":"4","author":"IH Su","year":"2002","unstructured":"Su, I. H. et al. Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat. Immunol. 4, 124\u2013131 (2002).","journal-title":"Nat. Immunol."},{"key":"1344_CR46","doi-asserted-by":"publisher","first-page":"10927","DOI":"10.1073\/pnas.1821301116","volume":"116","author":"T Arends","year":"2019","unstructured":"Arends, T. et al. CHD4 is essential for transcriptional repression and lineage progression in B lymphopoiesis. Proc. Natl Acad. Sci. USA 116, 10927\u201310936 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1344_CR47","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.celrep.2019.04.011","volume":"27","author":"WF Yen","year":"2019","unstructured":"Yen, W. F. et al. Distinct requirements of CHD4 during B cell development and antibody response. Cell Rep. 27, 1472\u20131486.e5 (2019).","journal-title":"Cell Rep."},{"key":"1344_CR48","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1038\/s41590-024-01995-7","volume":"25","author":"A Gamez-Garcia","year":"2024","unstructured":"Gamez-Garcia, A. et al. A SIRT7-dependent acetylation switch regulates early B cell differentiation and lineage commitment through Pax5. Nat. Immunol. 25, 2308\u20132319 (2024).","journal-title":"Nat. Immunol."},{"key":"1344_CR49","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.cell.2008.02.019","volume":"132","author":"A Ventura","year":"2008","unstructured":"Ventura, A. et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132, 875\u2013886 (2008).","journal-title":"Cell"},{"key":"1344_CR50","doi-asserted-by":"publisher","first-page":"7080","DOI":"10.1073\/pnas.0702409104","volume":"104","author":"B Zhou","year":"2007","unstructured":"Zhou, B., Wang, S., Mayr, C., Bartel, D. P. & Lodish, H. F. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc. Natl Acad. Sci. USA 104, 7080\u20137085 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1344_CR51","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.celrep.2019.06.029","volume":"28","author":"X Lu","year":"2019","unstructured":"Lu, X. et al. MTA2\/NuRD regulates B cell development and cooperates with OCA-B in controlling the pre-B to immature B cell transition. Cell Rep. 28, 472\u2013485.e5 (2019).","journal-title":"Cell Rep."},{"key":"1344_CR52","doi-asserted-by":"publisher","first-page":"107819","DOI":"10.1016\/j.celrep.2020.107819","volume":"31","author":"Z Zheng","year":"2020","unstructured":"Zheng, Z. et al. Control of early B cell development by the RNA N6-methyladenosine methylation. Cell Rep. 31, 107819 (2020).","journal-title":"Cell Rep."},{"key":"1344_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22458-9","volume":"12","author":"VS Mahajan","year":"2021","unstructured":"Mahajan, V. S. et al. B1a and B2 cells are characterized by distinct CpG modification states at DNMT3A-maintained enhancers. Nat. Commun. 12, 2208 (2021).","journal-title":"Nat. Commun."},{"key":"1344_CR54","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.4049\/jimmunol.1900654","volume":"203","author":"RR Haines","year":"2019","unstructured":"Haines, R. R., Scharer, C. D., Lobby, J. L. & Boss, J. M. LSD1 cooperates with noncanonical NF-\u03baB signaling to regulate marginal zone B cell development. J. Immunol. 203, 1867\u20131881 (2019).","journal-title":"J. Immunol."},{"key":"1344_CR55","doi-asserted-by":"publisher","first-page":"110778","DOI":"10.1016\/j.celrep.2022.110778","volume":"39","author":"A Grenov","year":"2022","unstructured":"Grenov, A., Hezroni, H., Lasman, L., Hanna, J. H. & Shulman, Z. YTHDF2 suppresses the plasmablast genetic program and promotes germinal center formation. Cell Rep. 39, 110778 (2022).","journal-title":"Cell Rep."},{"key":"1344_CR56","doi-asserted-by":"publisher","first-page":"eaau7523","DOI":"10.1126\/sciimmunol.aau7523","volume":"4","author":"CJ Lio","year":"2019","unstructured":"Lio, C. J. et al. TET enzymes augment activation-induced deaminase (AID) expression via 5-hydroxymethylcytosine modifications at the Aicda superenhancer. Sci. Immunol. 4, eaau7523 (2019). This study shows that TET enzymes deposit 5hmC at the Aicda superenhancer to enable full induction of AID expression, establishing a feed-forward epigenetic\u2013genetic circuit driving SHM and CSR during the GC response.","journal-title":"Sci. Immunol."},{"key":"1344_CR57","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210360","volume":"218","author":"AC Grenov","year":"2021","unstructured":"Grenov, A. C. et al. The germinal center reaction depends on RNA methylation and divergent functions of specific methyl readers. J. Exp. Med. 218, e20210360 (2021).","journal-title":"J. Exp. Med."},{"key":"1344_CR58","doi-asserted-by":"publisher","first-page":"705848","DOI":"10.3389\/fimmu.2021.705848","volume":"12","author":"D Schmiedel","year":"2021","unstructured":"Schmiedel, D., Hezroni, H., Hamburg, A. & Shulman, Z. Brg1 supports B cell proliferation and germinal center formation through enhancer activation. Front. Immunol. 12, 705848 (2021).","journal-title":"Front. Immunol."},{"key":"1344_CR59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20240433","volume":"221","author":"L Stoler-Barak","year":"2024","unstructured":"Stoler-Barak, L. et al. SMARCA5-mediated chromatin remodeling is required for germinal center formation. J. Exp. Med. 221, e20240433 (2024).","journal-title":"J. Exp. Med."},{"key":"1344_CR60","doi-asserted-by":"publisher","DOI":"10.1172\/JCI178920","volume":"135","author":"MC Sallan","year":"2025","unstructured":"Sallan, M. C. et al. Autophagy is an upstream mediator of chromatin dynamics in normal and autoimmune germinal center B cells. J. Clin. Invest. 135, e178920 (2025).","journal-title":"J. Clin. Invest."},{"key":"1344_CR61","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1016\/j.molcel.2021.07.037","volume":"81","author":"L Nair","year":"2021","unstructured":"Nair, L. et al. Mechanism of noncoding RNA-associated N6-methyladenosine recognition by an RNA processing complex during IgH DNA recombination. Mol. Cell 81, 3949\u20133964.e7 (2021).","journal-title":"Mol. Cell"},{"key":"1344_CR62","doi-asserted-by":"publisher","first-page":"eaay5872","DOI":"10.1126\/sciadv.aay5872","volume":"6","author":"W Rosikiewicz","year":"2020","unstructured":"Rosikiewicz, W. et al. TET2 deficiency reprograms the germinal center B cell epigenome and silences genes linked to lymphomagenesis. Sci. Adv. 6, eaay5872 (2020).","journal-title":"Sci. Adv."},{"key":"1344_CR63","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1182\/blood-2011-06-357996","volume":"118","author":"R Shaknovich","year":"2011","unstructured":"Shaknovich, R. et al. DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation. Blood 118, 3559\u20133569 (2011).","journal-title":"Blood"},{"key":"1344_CR64","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41590-021-01087-w","volume":"23","author":"V Shukla","year":"2021","unstructured":"Shukla, V. et al. TET deficiency perturbs mature B cell homeostasis and promotes oncogenesis associated with accumulation of G-quadruplex and R-loop structures. Nat. Immunol. 23, 99\u2013108 (2021).","journal-title":"Nat. Immunol."},{"key":"1344_CR65","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20111696","volume":"209","author":"JJ Taylor","year":"2012","unstructured":"Taylor, J. J., Pape, K. A. & Jenkins, M. K. A germinal center\u2013independent pathway generates unswitched memory B cells early in the primary response. J. Exp. Med. 209, 597\u2013606 (2012).","journal-title":"J. Exp. Med."},{"key":"1344_CR66","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.immuni.2019.07.001","volume":"51","author":"JA Roco","year":"2019","unstructured":"Roco, J. A. et al. Class-switch recombination occurs infrequently in germinal centers. Immunity 51, 337\u2013350.e7 (2019).","journal-title":"Immunity"},{"key":"1344_CR67","doi-asserted-by":"publisher","first-page":"eabe6291","DOI":"10.1126\/sciimmunol.abe6291","volume":"6","author":"HW King","year":"2021","unstructured":"King, H. W. et al. Single-cell analysis of human B cell maturation predicts how antibody class switching shapes selection dynamics. Sci. Immunol. 6, eabe6291 (2021).","journal-title":"Sci. Immunol."},{"key":"1344_CR68","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1016\/j.immuni.2025.10.022","volume":"58","author":"ER Siniscalco","year":"2025","unstructured":"Siniscalco, E. R. et al. Sequential class switching generates antigen-specific gut IgA from IgG1 B cells. Immunity 58, 3075\u20133093.e6 (2025).","journal-title":"Immunity"},{"key":"1344_CR69","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ccell.2024.02.010","volume":"42","author":"D Barisic","year":"2024","unstructured":"Barisic, D. et al. ARID1A orchestrates SWI\/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis. Cancer Cell 42, 583\u2013604 (2024).","journal-title":"Cancer Cell"},{"key":"1344_CR70","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1158\/2159-8290.CD-18-0657","volume":"8","author":"PM Dominguez","year":"2018","unstructured":"Dominguez, P. M. et al. TET2 deficiency causes germinal center hyperplasia, impairs plasma cell differentiation, and promotes B-cell lymphomagenesis. Cancer Discov. 8, 1632\u20131653 (2018).","journal-title":"Cancer Discov."},{"key":"1344_CR71","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.immuni.2024.03.016","volume":"57","author":"L Cooper","year":"2024","unstructured":"Cooper, L. et al. Type I interferons induce an epigenetically distinct memory B cell subset in chronic viral infection. Immunity 57, 1037\u20131055.e6 (2024).","journal-title":"Immunity"},{"key":"1344_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19242-6","volume":"11","author":"JB Moroney","year":"2020","unstructured":"Moroney, J. B., Vasudev, A., Pertsemlidis, A., Zan, H. & Casali, P. Integrative transcriptome and chromatin landscape analysis reveals distinct epigenetic regulations in human memory B cells. Nat. Commun. 11, 5435 (2020).","journal-title":"Nat. Commun."},{"key":"1344_CR73","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/ni.3519","volume":"17","author":"BG Barwick","year":"2016","unstructured":"Barwick, B. G., Scharer, C. D., Bally, A. P. R. & Boss, J. M. Plasma cell differentiation is coupled to division-dependent DNA hypomethylation and gene regulation. Nat. Immunol. 17, 1216\u20131225 (2016).","journal-title":"Nat. Immunol."},{"key":"1344_CR74","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.72313","volume":"11","author":"DJ Turner","year":"2022","unstructured":"Turner, D. J. et al. A functional screen of RNA binding proteins identifies genes that promote or limit the accumulation of CD138+ plasma cells. eLife 11, e2309290 (2022).","journal-title":"eLife"},{"key":"1344_CR75","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1073\/pnas.1617959114","volume":"114","author":"CFA de Bourcy","year":"2017","unstructured":"de Bourcy, C. F. A. et al. Phylogenetic analysis of the human antibody repertoire reveals quantitative signatures of immune senescence and aging. Proc. Natl Acad. Sci. USA 114, 1105\u20131110 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1344_CR76","doi-asserted-by":"publisher","first-page":"eadv7615","DOI":"10.1126\/sciimmunol.adv7615","volume":"11","author":"S Khan","year":"2026","unstructured":"Khan, S. et al. B cells drive CD4 T cell immunosenescence and age-associated health decline. Sci. Immunol. 11, eadv7615 (2026).","journal-title":"Sci. Immunol."},{"key":"1344_CR77","doi-asserted-by":"publisher","first-page":"733566","DOI":"10.3389\/fimmu.2021.733566","volume":"12","author":"J de Mol","year":"2021","unstructured":"de Mol, J., Kuiper, J., Tsiantoulas, D. & Foks, A. C. The dynamics of B cell aging in health and disease. Front. Immunol. 12, 733566 (2021).","journal-title":"Front. Immunol."},{"key":"1344_CR78","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20231314","volume":"221","author":"J Deguine","year":"2024","unstructured":"Deguine, J. & Xavier, R. J. B cell tolerance and autoimmunity: lessons from repertoires. J. Exp. Med. 221, e20231314 (2024).","journal-title":"J. Exp. Med."},{"key":"1344_CR79","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nri.2017.19","volume":"17","author":"D Nemazee","year":"2017","unstructured":"Nemazee, D. Mechanisms of central tolerance for B cells. Nat. Rev. Immunol. 17, 281\u2013294 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"1344_CR80","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1146\/annurev-immunol-051116-052510","volume":"36","author":"R Brink","year":"2018","unstructured":"Brink, R. & Phan, T. G. Self-reactive B cells in the germinal center reaction. Annu. Rev. Immunol. 36, 339\u2013357 (2018).","journal-title":"Annu. Rev. Immunol."},{"key":"1344_CR81","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/nature03724","volume":"435","author":"CC Goodnow","year":"2005","unstructured":"Goodnow, C. C., Sprent, J., Fazekas de St Groth, B. & Vinuesa, C. G. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435, 590\u2013597 (2005).","journal-title":"Nature"},{"key":"1344_CR82","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1084\/jem.177.4.1009","volume":"177","author":"SL Tiegs","year":"1993","unstructured":"Tiegs, S. L., Russell, D. M. & Nemazee, D. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177, 1009\u20131020 (1993). This study demonstrates that immature self-reactive B cells in the bone marrow undergo secondary V(D)J rearrangement to revise their BCR specificity rather than undergo deletion, establishing receptor editing as the principal central tolerance mechanism.","journal-title":"J. Exp. Med."},{"key":"1344_CR83","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0092-8674(93)90111-3","volume":"72","author":"SB Hartley","year":"1993","unstructured":"Hartley, S. B. et al. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 72, 325\u2013335 (1993).","journal-title":"Cell"},{"key":"1344_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12207","volume":"7","author":"M Lai","year":"2016","unstructured":"Lai, M. et al. Regulation of B-cell development and tolerance by different members of the miR-17\u223c92 family microRNAs. Nat. Commun. 7, 12207 (2016).","journal-title":"Nat. Commun."},{"key":"1344_CR85","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1084\/jem.20030411","volume":"198","author":"A Enders","year":"2003","unstructured":"Enders, A. et al. Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J. Exp. Med. 198, 1119\u20131126 (2003).","journal-title":"J. Exp. Med."},{"key":"1344_CR86","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1126\/science.286.5445.1735","volume":"286","author":"P Bouillet","year":"1999","unstructured":"Bouillet, P. et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286, 1735\u20131738 (1999).","journal-title":"Science"},{"key":"1344_CR87","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.celrep.2016.05.084","volume":"16","author":"D Benhamou","year":"2016","unstructured":"Benhamou, D. et al. A c-Myc\/miR17-92\/Pten axis controls PI3K-mediated positive and negative selection in B cell development and reconstitutes CD19 deficiency. Cell Rep. 16, 419\u2013431 (2016).","journal-title":"Cell Rep."},{"key":"1344_CR88","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1084\/jem.20042251","volume":"201","author":"S Yurasov","year":"2005","unstructured":"Yurasov, S. et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med. 201, 703\u2013711 (2005). This study uses single-cell antibody cloning to document defective B cell tolerance checkpoints in patients with SLE, showing that both central and peripheral checkpoints fail to purge autoreactive clones.","journal-title":"J. Exp. Med."},{"key":"1344_CR89","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/334676a0","volume":"334","author":"CC Goodnow","year":"1988","unstructured":"Goodnow, C. C. et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334, 676\u2013682 (1988). This study provides the first in vivo evidence that tolerance can be enforced through reversible signalling tuning rather than clonal elimination, seeding the field\u2019s quantitative-rheostat view of tolerance.","journal-title":"Nature"},{"key":"1344_CR90","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1084\/jem.191.5.883","volume":"191","author":"KL Hippen","year":"2000","unstructured":"Hippen, K. L., Tze, L. E. & Behrens, T. W. CD5 maintains tolerance in anergic B cells. J. Exp. Med. 191, 883\u2013890 (2000).","journal-title":"J. Exp. Med."},{"key":"1344_CR91","doi-asserted-by":"publisher","first-page":"5623","DOI":"10.4049\/jimmunol.0802412","volume":"182","author":"S Garaud","year":"2009","unstructured":"Garaud, S. et al. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. J. Immunol. 182, 5623\u20135632 (2009).","journal-title":"J. Immunol."},{"key":"1344_CR92","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1084\/jem.20080611","volume":"206","author":"JA Duty","year":"2008","unstructured":"Duty, J. A. et al. Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors. J. Exp. Med. 206, 139\u2013151 (2008).","journal-title":"J. Exp. Med."},{"key":"1344_CR93","doi-asserted-by":"publisher","first-page":"102440","DOI":"10.1016\/j.jaut.2020.102440","volume":"109","author":"M Wang","year":"2020","unstructured":"Wang, M. et al. Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development. J. Autoimmun. 109, 102440 (2020).","journal-title":"J. Autoimmun."},{"key":"1344_CR94","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nri2621","volume":"9","author":"MP Cancro","year":"2009","unstructured":"Cancro, M. P. Signalling crosstalk in B cells: managing worth and need. Nat. Rev. Immunol. 9, 657\u2013661 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"1344_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007050","volume":"13","author":"CM Syrett","year":"2017","unstructured":"Syrett, C. M. et al. Loss of Xist RNA from the inactive X during B cell development is restored in a dynamic YY1-dependent two-step process in activated B cells. PLoS Genet. 13, e1007050 (2017).","journal-title":"PLoS Genet."},{"key":"1344_CR96","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.cell.2018.11.041","volume":"176","author":"JJ \u017bylicz","year":"2018","unstructured":"\u017bylicz, J. J. et al. The implication of early chromatin changes in X chromosome inactivation. Cell 176, 182\u2013197.e23 (2018).","journal-title":"Cell"},{"key":"1344_CR97","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.169344","volume":"8","author":"JD Crawford","year":"2023","unstructured":"Crawford, J. D. et al. The XIST lncRNA is a sex-specific reservoir of TLR7 ligands in SLE. JCI Insight 8, e169344 (2023).","journal-title":"JCI Insight"},{"key":"1344_CR98","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/s41590-024-01858-1","volume":"25","author":"RA Elsner","year":"2024","unstructured":"Elsner, R. A., Smita, S. & Shlomchik, M. J. IL-12 induces a B cell-intrinsic IL-12\/IFN\u03b3 feed-forward loop promoting extrafollicular B cell responses. Nat. Immunol. 25, 1283\u20131295 (2024).","journal-title":"Nat. Immunol."},{"key":"1344_CR99","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1126\/science.adf8531","volume":"383","author":"D Dai","year":"2024","unstructured":"Dai, D. et al. The transcription factor ZEB2 drives the formation of age-associated B cells. Science 383, 413\u2013421 (2024).","journal-title":"Science"},{"key":"1344_CR100","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ajhg.2012.11.018","volume":"92","author":"W Yang","year":"2012","unstructured":"Yang, W. et al. Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians. Am. J. Hum. Genet. 92, 41\u201351 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"1344_CR101","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/art.39403","volume":"68","author":"FY Demirci","year":"2016","unstructured":"Demirci, F. Y. et al. Identification of a new susceptibility locus for systemic lupus erythematosus on chromosome 12 in individuals of European ancestry. Arthritis Rheumatol. 68, 174\u2013183 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"1344_CR102","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1016\/j.immuni.2025.08.007","volume":"58","author":"SC Eisenbarth","year":"2025","unstructured":"Eisenbarth, S. C. et al. A roadmap for defining \u201cextrafollicular\u201d B cell responses. Immunity 58, 2627\u20132645 (2025).","journal-title":"Immunity"},{"key":"1344_CR103","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/art.40422","volume":"70","author":"CJ Ulff-M\u00f8ller","year":"2018","unstructured":"Ulff-M\u00f8ller, C. J. et al. Twin DNA methylation profiling reveals flare-dependent interferon signature and B cell promoter hypermethylation in systemic lupus erythematosus. Arthritis Rheumatol. 70, 878\u2013890 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"1344_CR104","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2217\/epi.15.103","volume":"8","author":"JR Glossop","year":"2016","unstructured":"Glossop, J. R. et al. Genome-wide profiling in treatment-naive early rheumatoid arthritis reveals DNA methylome changes in T and B lymphocytes. Epigenomics 8, 209\u2013224 (2016).","journal-title":"Epigenomics"},{"key":"1344_CR105","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1093\/hmg\/ddx177","volume":"26","author":"A Juli\u00e0","year":"2017","unstructured":"Juli\u00e0, A. et al. Epigenome-wide association study of rheumatoid arthritis identifies differentially methylated loci in B cells. Hum. Mol. Genet. 26, 2803\u20132811 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"1344_CR106","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/annrheumdis-2014-206998","volume":"75","author":"C Miceli-Richard","year":"2016","unstructured":"Miceli-Richard, C. et al. Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sj\u00f6gren\u2019s syndrome. Ann. Rheum. Dis. 75, 933\u2013940 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"1344_CR107","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2111920118","volume":"118","author":"Q Ma","year":"2021","unstructured":"Ma, Q. et al. Specific hypomethylation programs underpin B cell activation in early multiple sclerosis. Proc. Natl Acad. Sci. USA 118, e2111920118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1344_CR108","doi-asserted-by":"publisher","first-page":"102027","DOI":"10.1016\/j.xcrm.2025.102027","volume":"6","author":"I Jelcic","year":"2025","unstructured":"Jelcic, I. et al. T-bet+CXCR3+B cells drive hyperreactive B\u2013T cell interactions in multiple sclerosis. Cell Rep. Med. 6, 102027 (2025).","journal-title":"Cell Rep. Med."},{"key":"1344_CR109","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/ana.25508","volume":"86","author":"J van Langelaar","year":"2019","unstructured":"van Langelaar, J. et al. Induction of brain-infiltrating T-bet-expressing B cells in multiple sclerosis. Ann. Neurol. 86, 264\u2013278 (2019).","journal-title":"Ann. Neurol."},{"key":"1344_CR110","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/brain\/awm038","volume":"130","author":"R Magliozzi","year":"2007","unstructured":"Magliozzi, R. et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130, 1089\u20131104 (2007).","journal-title":"Brain"},{"key":"1344_CR111","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature10251","volume":"476","author":"S Sawcer","year":"2011","unstructured":"Sawcer, S. et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214\u2013219 (2011).","journal-title":"Nature"},{"key":"1344_CR112","doi-asserted-by":"publisher","first-page":"eaay2793","DOI":"10.1126\/sciadv.aay2793","volume":"6","author":"H Gan","year":"2020","unstructured":"Gan, H. et al. B cell Sirt1 deacetylates histone and non-histone proteins for epigenetic modulation of AID expression and the antibody response. Sci. Adv. 6, eaay2793 (2020).","journal-title":"Sci. Adv."},{"key":"1344_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13603-6","volume":"11","author":"HN Sanchez","year":"2020","unstructured":"Sanchez, H. N. et al. B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids. Nat. Commun. 11, 60 (2020).","journal-title":"Nat. Commun."},{"key":"1344_CR114","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.clim.2013.06.006","volume":"149","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Aberrant histone modification in peripheral blood B cells from patients with systemic sclerosis. Clin. Immunol. 149, 46\u201354 (2013).","journal-title":"Clin. Immunol."},{"key":"1344_CR115","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3389\/fimmu.2020.00491","volume":"11","author":"P Casali","year":"2020","unstructured":"Casali, P. et al. Estrogen reverses HDAC inhibitor-mediated repression of Aicda and class-switching in antibody and autoantibody responses by downregulation of miR-26a. Front. Immunol. 11, 491 (2020).","journal-title":"Front. Immunol."},{"key":"1344_CR116","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1093\/nar\/gky281","volume":"46","author":"KH Hung","year":"2018","unstructured":"Hung, K. H. et al. The KDM4A\/KDM4C\/NF-\u03baB and WDR5 epigenetic cascade regulates the activation of B cells. Nucleic Acids Res. 46, 5547\u20135560 (2018).","journal-title":"Nucleic Acids Res."},{"key":"1344_CR117","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41590-022-01287-y","volume":"23","author":"Y Yin","year":"2022","unstructured":"Yin, Y. et al. Jmjd1c demethylates STAT3 to restrain plasma cell differentiation and rheumatoid arthritis. Nat. Immunol. 23, 1342\u20131354 (2022).","journal-title":"Nat. Immunol."},{"key":"1344_CR118","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/art.41208","volume":"72","author":"M Zhang","year":"2020","unstructured":"Zhang, M. et al. Methionine commits cells to differentiate into plasmablasts through epigenetic regulation of BTB and CNC homolog 2 by the methyltransferase EZH2. Arthritis Rheumatol. 72, 1143\u20131153 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"1344_CR119","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.4049\/jimmunol.1701470","volume":"200","author":"M Guo","year":"2017","unstructured":"Guo, M. et al. EZH2 represses the B cell transcriptional program and regulates antibody-secreting cell metabolism and antibody production. J. Immunol. 200, 1039\u20131052 (2017).","journal-title":"J. Immunol."},{"key":"1344_CR120","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2023-000921","volume":"10","author":"J Hui-Yuen","year":"2023","unstructured":"Hui-Yuen, J. et al. B lymphocytes in treatment-naive paediatric patients with lupus are epigenetically distinct from healthy children. Lupus Sci. Med. 10, e000921 (2023).","journal-title":"Lupus Sci. Med."},{"key":"1344_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/srep27030","volume":"6","author":"CD Scharer","year":"2016","unstructured":"Scharer, C. D. et al. ATAC-seq on biobanked specimens defines a unique chromatin accessibility structure in na\u00efve SLE B cells. Sci. Rep. 6, 27030 (2016).","journal-title":"Sci. Rep."},{"key":"1344_CR122","doi-asserted-by":"publisher","first-page":"641886","DOI":"10.3389\/fimmu.2021.641886","volume":"12","author":"H Yu","year":"2021","unstructured":"Yu, H. et al. The chromatin accessibility landscape of peripheral blood mononuclear cells in patients with systemic lupus erythematosus at single-cell resolution. Front. Immunol. 12, 641886 (2021).","journal-title":"Front. Immunol."},{"key":"1344_CR123","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41590-018-0056-8","volume":"19","author":"M Manni","year":"2018","unstructured":"Manni, M. et al. Regulation of age-associated B cells by IRF5 in systemic autoimmunity. Nat. Immunol. 19, 407\u2013419 (2018).","journal-title":"Nat. Immunol."},{"key":"1344_CR124","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41588-018-0102-3","volume":"50","author":"JB Harley","year":"2018","unstructured":"Harley, J. B. et al. Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat. Genet. 50, 699\u2013707 (2018).","journal-title":"Nat. Genet."},{"key":"1344_CR125","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1101\/gr.264705.120","volume":"31","author":"T Hong","year":"2021","unstructured":"Hong, T. et al. Epstein\u2013Barr virus nuclear antigen 2 extensively rewires the human chromatin landscape at autoimmune risk loci. Genome Res. 31, 2185\u20132198 (2021).","journal-title":"Genome Res."},{"key":"1344_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02694-y","volume":"23","author":"MH Guo","year":"2022","unstructured":"Guo, M. H. et al. Dissection of multiple sclerosis genetics identifies B and CD4+ T cells as driver cell subsets. Genome Biol. 23, 127 (2022).","journal-title":"Genome Biol."},{"key":"1344_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54941-4","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Aberrant METTL1-mediated tRNA m7G modification alters B-cell responses in systemic autoimmunity in humans and mice. Nat. Commun. 15, 10599 (2024).","journal-title":"Nat. Commun."},{"key":"1344_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03735-y","volume":"22","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. METTL3 facilitates kidney injury through promoting IRF4-mediated plasma cell infiltration via an m6A-dependent manner in systemic lupus erythematosus. BMC Med. 22, 511 (2024).","journal-title":"BMC Med."},{"key":"1344_CR129","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s10020-025-01295-2","volume":"31","author":"Y Yang","year":"2025","unstructured":"Yang, Y. et al. Reciprocal METTL3\u2013PAX5 regulation in maintaining B-cell identity and promoting B-cell hyperreactivity in SLE. Mol. Med. 31, 236 (2025).","journal-title":"Mol. Med."},{"key":"1344_CR130","doi-asserted-by":"publisher","first-page":"eadu6015","DOI":"10.1126\/scitranslmed.adu6015","volume":"17","author":"Q Zeng","year":"2025","unstructured":"Zeng, Q. et al. The m6A demethylase FTO links TLR7 to mitochondrial oxidation driving age-associated B cell formation in systemic lupus erythematosus. Sci. Transl. Med. 17, eadu6015 (2025).","journal-title":"Sci. Transl. Med."},{"key":"1344_CR131","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/art.43046","volume":"77","author":"L Tan","year":"2024","unstructured":"Tan, L. et al. FoxO1 deficiency in monocytic myeloid-derived suppressor cells exacerbates B cell dysfunction in systemic lupus erythematosus. Arthritis Rheumatol. 77, 423\u2013438 (2024).","journal-title":"Arthritis Rheumatol."},{"key":"1344_CR132","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-015-0063-7","volume":"7","author":"S Luo","year":"2015","unstructured":"Luo, S. et al. The role of microRNA-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus. Clin. Epigenetics 7, 24 (2015).","journal-title":"Clin. Epigenetics"},{"key":"1344_CR133","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3389\/fimmu.2019.01127","volume":"10","author":"S Luo","year":"2019","unstructured":"Luo, S. et al. Excessive miR-152-3p results in increased BAFF expression in SLE B-cells by inhibiting the KLF5 expression. Front. Immunol. 10, 1127 (2019).","journal-title":"Front. Immunol."},{"key":"1344_CR134","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/art.41987","volume":"74","author":"L Xu","year":"2022","unstructured":"Xu, L. et al. Up-regulated interleukin-10 induced by E2F transcription factor 2\u2013microRNA-17-5p circuitry in extrafollicular effector B cells contributes to autoantibody production in systemic lupus erythematosus. Arthritis Rheumatol. 74, 496\u2013507 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"1344_CR135","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.4049\/jimmunol.2001039","volume":"206","author":"SL Schell","year":"2021","unstructured":"Schell, S. L. et al. Context-dependent miR-21 regulation of TLR7-mediated autoimmune and foreign antigen-driven antibody-forming cell and germinal center responses. J. Immunol. 206, 2803\u20132818 (2021).","journal-title":"J. Immunol."},{"key":"1344_CR136","doi-asserted-by":"publisher","first-page":"20194","DOI":"10.1073\/pnas.1317632110","volume":"110","author":"T-H Thai","year":"2013","unstructured":"Thai, T.-H. et al. Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Faslpr mouse. Proc. Natl Acad. Sci. USA 110, 20194\u201320199 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1344_CR137","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.4049\/jimmunol.1403028","volume":"194","author":"Q Xin","year":"2015","unstructured":"Xin, Q. et al. miR-155 deficiency ameliorates autoimmune inflammation of systemic lupus erythematosus by targeting S1pr1 in Faslpr\/lpr mice. J. Immunol. 194, 5437\u20135445 (2015).","journal-title":"J. Immunol."},{"key":"1344_CR138","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12970","volume":"7","author":"S Alivernini","year":"2016","unstructured":"Alivernini, S. et al. microRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis. Nat. Commun. 7, 12970 (2016).","journal-title":"Nat. Commun."},{"key":"1344_CR139","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s00018-017-2456-6","volume":"74","author":"A van Nieuwenhuijze","year":"2017","unstructured":"van Nieuwenhuijze, A. et al. Defective germinal center B-cell response and reduced arthritic pathology in microRNA-29a-deficient mice. Cell. Mol. Life Sci. 74, 2095\u20132106 (2017).","journal-title":"Cell. Mol. Life Sci."},{"key":"1344_CR140","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/annrheumdis-2017-211417","volume":"77","author":"S-F Wang-Renault","year":"2018","unstructured":"Wang-Renault, S.-F. et al. Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sj\u00f6gren\u2019s syndrome. Ann. Rheum. Dis. 77, 133\u2013140 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"1344_CR141","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.clim.2012.04.002","volume":"144","author":"C Sievers","year":"2012","unstructured":"Sievers, C. et al. Altered microRNA expression in B lymphocytes in multiple sclerosis. Clin. Immunol. 144, 70\u201379 (2012).","journal-title":"Clin. Immunol."},{"key":"1344_CR142","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2024624118","volume":"118","author":"S Pyfrom","year":"2021","unstructured":"Pyfrom, S. et al. The dynamic epigenetic regulation of the inactive X chromosome in healthy human B cells is dysregulated in lupus patients. Proc. Natl Acad. Sci. USA 118, e2024624118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1344_CR143","doi-asserted-by":"publisher","first-page":"eaap8855","DOI":"10.1126\/sciimmunol.aap8855","volume":"3","author":"M Souyris","year":"2018","unstructured":"Souyris, M. et al. TLR7 escapes X chromosome inactivation in immune cells. Sci. Immunol. 3, eaap8855 (2018).","journal-title":"Sci. Immunol."},{"key":"1344_CR144","doi-asserted-by":"publisher","first-page":"1021370","DOI":"10.3389\/fimmu.2022.1021370","volume":"13","author":"LF Voss","year":"2022","unstructured":"Voss, L. F. et al. The extrafollicular response is sufficient to drive initiation of autoimmunity and early disease hallmarks of lupus. Front. Immunol. 13, 1021370 (2022).","journal-title":"Front. Immunol."},{"key":"1344_CR145","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.cell.2023.12.037","volume":"187","author":"DR Dou","year":"2024","unstructured":"Dou, D. R. et al. Xist ribonucleoproteins promote female sex-biased autoimmunity. Cell 187, 733\u2013749 (2024). Together with Yu, B. et al. (2021) and Crawford et al. (2023), this work supports a model in which XIST ribonucleoprotein complexes can act not only as intracellular epigenetic regulators but also as autoantigen-like stimuli, contributing to the female bias of systemic autoimmune diseases.","journal-title":"Cell"},{"key":"1344_CR146","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.immuni.2016.09.001","volume":"45","author":"L Mesin","year":"2016","unstructured":"Mesin, L., Ersching, J. & Victora, G. D. Germinal center B cell dynamics. Immunity 45, 471\u2013482 (2016).","journal-title":"Immunity"},{"key":"1344_CR147","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1002\/art.20255","volume":"50","author":"K Oelke","year":"2004","unstructured":"Oelke, K. et al. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. Arthritis Rheum. 50, 1850\u20131860 (2004).","journal-title":"Arthritis Rheum."},{"key":"1344_CR148","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.4049\/jimmunol.179.9.6352","volume":"179","author":"Q Lu","year":"2007","unstructured":"Lu, Q. et al. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J. Immunol. 179, 6352\u20136358 (2007).","journal-title":"J. Immunol."},{"key":"1344_CR149","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.781","volume":"12","author":"H Wu","year":"2022","unstructured":"Wu, H. et al. The IL-21\u2013TET2\u2013AIM2\u2013c-MAF pathway drives the T follicular helper cell response in lupus-like disease. Clin. Transl. Med. 12, e781 (2022).","journal-title":"Clin. Transl. Med."},{"key":"1344_CR150","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13075-020-02225-9","volume":"22","author":"Y Zhen","year":"2020","unstructured":"Zhen, Y., Smith, R. D., Finkelman, F. D. & Shao, W.-H. Ezh2-mediated epigenetic modification is required for allogeneic T cell-induced lupus disease. Arthritis Res. Ther. 22, 133 (2020).","journal-title":"Arthritis Res. Ther."},{"key":"1344_CR151","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41423-019-0268-3","volume":"17","author":"S Ding","year":"2020","unstructured":"Ding, S. et al. BCL-6 suppresses miR-142-3p\/5p expression in SLE CD4+ T cells by modulating histone methylation and acetylation of the miR-142 promoter. Cell. Mol. Immunol. 17, 474\u2013482 (2020).","journal-title":"Cell. Mol. Immunol."},{"key":"1344_CR152","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.immuni.2014.09.015","volume":"41","author":"R Hu","year":"2014","unstructured":"Hu, R. et al. miR-155 promotes T follicular helper cell accumulation during chronic, low-grade inflammation. Immunity 41, 605\u2013619 (2014).","journal-title":"Immunity"},{"key":"1344_CR153","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2013.04.034","volume":"153","author":"T Uehata","year":"2013","unstructured":"Uehata, T. et al. Malt1-induced cleavage of regnase-1 in CD4+ helper T cells regulates immune activation. Cell 153, 1036\u20131049 (2013).","journal-title":"Cell"},{"key":"1344_CR154","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1470-2045(09)70003-8","volume":"10","author":"P Fenaux","year":"2009","unstructured":"Fenaux, P. et al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol. 10, 223\u2013232 (2009).","journal-title":"Lancet Oncol."},{"key":"1344_CR155","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1056\/NEJMoa2004444","volume":"383","author":"AH Wei","year":"2020","unstructured":"Wei, A. H. et al. Oral azacitidine maintenance therapy for acute myeloid leukemia in first remission. N. Engl. J. Med. 383, 2526\u20132537 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1344_CR156","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1038\/s41375-022-01698-8","volume":"36","author":"A Mekinian","year":"2022","unstructured":"Mekinian, A. et al. A phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune\/inflammatory disorders and VEXAS syndrome associated with MDS and CMML. Leukemia 36, 2739\u20132742 (2022).","journal-title":"Leukemia"},{"key":"1344_CR157","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1172\/JCI116576","volume":"92","author":"J Quddus","year":"1993","unstructured":"Quddus, J. et al. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J. Clin. Invest. 92, 38\u201353 (1993).","journal-title":"J. Clin. Invest."},{"key":"1344_CR158","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/art.40877","volume":"71","author":"DM T\u00f3th","year":"2019","unstructured":"T\u00f3th, D. M. et al. Amelioration of autoimmune arthritis in mice treated with the DNA methyltransferase inhibitor 5\u2019-azacytidine. Arthritis Rheumatol. 71, 1265\u20131275 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"1344_CR159","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7838","volume":"6","author":"M Waibel","year":"2015","unstructured":"Waibel, M. et al. Manipulation of B-cell responses with histone deacetylase inhibitors. Nat. Commun. 6, 6838 (2015).","journal-title":"Nat. Commun."},{"key":"1344_CR160","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1182\/blood-2018-05-847624","volume":"133","author":"H-Y Zhao","year":"2018","unstructured":"Zhao, H.-Y. et al. Low-dose chidamide restores immune tolerance in ITP in mice and humans. Blood 133, 730\u2013742 (2018).","journal-title":"Blood"},{"key":"1344_CR161","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.clim.2015.11.007","volume":"162","author":"NL Regna","year":"2016","unstructured":"Regna, N. L. et al. Specific HDAC6 inhibition by ACY-738 reduces SLE pathogenesis in NZB\/W mice. Clin. Immunol. 162, 58\u201373 (2016).","journal-title":"Clin. Immunol."},{"key":"1344_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.144","volume":"49","author":"JP Jhou","year":"2017","unstructured":"Jhou, J. P. et al. Upregulation of Fc\u03b3RIIB by resveratrol via NF-\u03baB activation reduces B-cell numbers and ameliorates lupus. Exp. Mol. Med. 49, e381 (2017).","journal-title":"Exp. Mol. Med."},{"key":"1344_CR163","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.intimp.2015.10.036","volume":"29","author":"S Wei","year":"2015","unstructured":"Wei, S., Sun, Y. & Sha, H. Therapeutic targeting of BET protein BRD4 delays murine lupus. Int. Immunopharmacol. 29, 314\u2013319 (2015).","journal-title":"Int. Immunopharmacol."},{"key":"1344_CR164","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1182\/blood.2021014557","volume":"139","author":"MC Zaiken","year":"2022","unstructured":"Zaiken, M. C. et al. BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes. Blood 139, 2983\u20132997 (2022).","journal-title":"Blood"},{"key":"1344_CR165","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1002\/art.40931","volume":"71","author":"DM Rohraff","year":"2019","unstructured":"Rohraff, D. M. et al. Inhibition of EZH2 ameliorates lupus-like disease in MRL\/lpr mice. Arthritis Rheumatol. 71, 1681\u20131690 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"1344_CR166","doi-asserted-by":"publisher","first-page":"1180302","DOI":"10.3389\/fbioe.2023.1180302","volume":"11","author":"H Guo","year":"2023","unstructured":"Guo, H. et al. Delivery of antagomiR-7 through polymer nanoparticles for assisting B Cell to alleviate systemic lupus erythematosus. Front. Bioeng. Biotechnol. 11, 1180302 (2023).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"1344_CR167","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41392-024-02039-0","volume":"9","author":"W Dai","year":"2024","unstructured":"Dai, W. et al. Epigenetics-targeted drugs: current paradigms and future challenges. Signal. Transduct. Target. Ther. 9, 332 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1344_CR168","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.1073\/pnas.1604365113","volume":"113","author":"S Orlanski","year":"2016","unstructured":"Orlanski, S. et al. Tissue-specific DNA demethylation is required for proper B-cell differentiation and function. Proc. Natl Acad. Sci. USA 113, 5018\u20135023 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1344_CR169","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1038\/s41592-025-02847-4","volume":"22","author":"C Geisenberger","year":"2025","unstructured":"Geisenberger, C. et al. Single-cell multi-omic detection of DNA methylation and histone modifications reconstructs the dynamics of epigenomic maintenance. Nat. Methods 22, 2042\u20132051 (2025).","journal-title":"Nat. Methods"},{"key":"1344_CR170","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrg2540","volume":"10","author":"H Cedar","year":"2009","unstructured":"Cedar, H. & Bergman, Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet. 10, 295\u2013304 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"1344_CR171","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41392-024-02030-9","volume":"9","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. Signal. Transduct. Target. Ther. 9, 340 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1344_CR172","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003678","volume":"9","author":"DM Absher","year":"2013","unstructured":"Absher, D. M. et al. Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet. 9, e1003678 (2013).","journal-title":"PLoS Genet."},{"key":"1344_CR173","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nrrheum.2017.147","volume":"13","author":"E Ballestar","year":"2017","unstructured":"Ballestar, E. & Li, T. New insights into the epigenetics of inflammatory rheumatic diseases. Nat. Rev. Rheumatol. 13, 593\u2013605 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1344_CR174","doi-asserted-by":"publisher","first-page":"eabh3768","DOI":"10.1126\/sciimmunol.abh3768","volume":"6","author":"HW King","year":"2021","unstructured":"King, H. W. et al. Integrated single-cell transcriptomics and epigenomics reveals strong germinal center-associated etiology of autoimmune risk loci. Sci. Immunol. 6, eabh3768 (2021).","journal-title":"Sci. Immunol."},{"key":"1344_CR175","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41586-025-09686-5","volume":"648","author":"Q Gong","year":"2025","unstructured":"Gong, Q. et al. Multi-omic profiling reveals age-related immune dynamics in healthy adults. Nature 648, 696\u2013706 (2025).","journal-title":"Nature"},{"key":"1344_CR176","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/s41556-024-01424-9","volume":"26","author":"F Ma","year":"2024","unstructured":"Ma, F. et al. Three-dimensional chromatin reorganization regulates B cell development during ageing. Nat. Cell Biol. 26, 991\u20131002 (2024). This study reveals that large-scale chromatin reorganization \u2014 characterized by increased inter-compartment interactions and reduced interactions within topologically associated domains \u2014 distinguishes aged pro-B cells from young pro-B cells, and that these 3D architectural changes impair V(D)J recombination and B lymphopoiesis.","journal-title":"Nat. Cell Biol."},{"key":"1344_CR177","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04234-4","volume":"9","author":"BG Barwick","year":"2018","unstructured":"Barwick, B. G. et al. B cell activation and plasma cell differentiation are inhibited by de novo DNA methylation. Nat. Commun. 9, 1900 (2018).","journal-title":"Nat. Commun."},{"key":"1344_CR178","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.immuni.2004.05.010","volume":"20","author":"M Thien","year":"2004","unstructured":"Thien, M. et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20, 785\u2013798 (2004).","journal-title":"Immunity"},{"key":"1344_CR179","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1056\/NEJMoa032534","volume":"350","author":"JCW Edwards","year":"2004","unstructured":"Edwards, J. C. W. et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 350, 2572\u20132581 (2004). This clinical trial demonstrates that B cell depletion with rituximab is an effective treatment for rheumatoid arthritis, validating the pathogenic role of B cells in this autoimmune disease.","journal-title":"N. Engl. J. Med."},{"key":"1344_CR180","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa1601277","volume":"376","author":"SL Hauser","year":"2016","unstructured":"Hauser, S. L. et al. Ocrelizumab versus interferon \u03b21a in relapsing multiple sclerosis. N. Engl. J. Med. 376, 221\u2013234 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1344_CR181","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","volume":"28","author":"A Mackensen","year":"2022","unstructured":"Mackensen, A. et al. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. Nat. Med. 28, 2124\u20132132 (2022). This clinical study provides proof of concept that anti-CD19 CAR-T cell therapy can induce remission in patients with refractory SLE, demonstrating comprehensive B cell depletion beyond the reach of rituximab to include short-lived plasmablasts, and sets a new benchmark for epigenetic therapies.","journal-title":"Nat. Med."},{"key":"1344_CR182","doi-asserted-by":"publisher","first-page":"6414","DOI":"10.1016\/j.cell.2025.09.020","volume":"188","author":"C Qin","year":"2025","unstructured":"Qin, C. et al. Anti-BCMA CAR-T therapy in patients with progressive multiple sclerosis. Cell 188, 6414\u20136423.e11 (2025).","journal-title":"Cell"},{"key":"1344_CR183","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1172\/JCI65689","volume":"123","author":"M Mah\u00e9vas","year":"2012","unstructured":"Mah\u00e9vas, M. et al. B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells. J. Clin. Invest. 123, 432\u2013442 (2012).","journal-title":"J. Clin. Invest."},{"key":"1344_CR184","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.jaci.2022.10.035","volume":"151","author":"J Koers","year":"2023","unstructured":"Koers, J. et al. Differences in IgG autoantibody Fab glycosylation across autoimmune diseases. J. Allergy Clin. Immunol. 151, 1646\u20131654 (2023).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1344_CR185","doi-asserted-by":"publisher","first-page":"eabm1759","DOI":"10.1126\/sciadv.abm1759","volume":"8","author":"T Kissel","year":"2022","unstructured":"Kissel, T. et al. Surface Ig variable domain glycosylation affects autoantigen binding and acts as threshold for human autoreactive B cell activation. Sci. Adv. 8, eabm1759 (2022).","journal-title":"Sci. Adv."},{"key":"1344_CR186","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1038\/s41591-025-03937-8","volume":"31","author":"J Feng","year":"2025","unstructured":"Feng, J. et al. Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial. Nat. Med. 31, 3725\u20133736 (2025).","journal-title":"Nat. Med."},{"key":"1344_CR187","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3389\/fimmu.2018.01473","volume":"9","author":"H Zhang","year":"2018","unstructured":"Zhang, H. et al. B cell-related circulating microRNAs with the potential value of biomarkers in the differential diagnosis, and distinguishment between the disease activity and lupus nephritis for systemic lupus erythematosus. Front. Immunol. 9, 1473 (2018).","journal-title":"Front. Immunol."},{"key":"1344_CR188","doi-asserted-by":"publisher","first-page":"eabf1970","DOI":"10.1126\/science.abf1970","volume":"376","author":"RK Perez","year":"2022","unstructured":"Perez, R. K. et al. Single-cell RNA-seq reveals cell type-specific molecular and genetic associations to lupus. Science 376, eabf1970 (2022).","journal-title":"Science"},{"key":"1344_CR189","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1084\/jem.177.4.999","volume":"177","author":"D Gay","year":"1993","unstructured":"Gay, D., Saunders, T., Camper, S. & Weigert, M. Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177, 999\u20131008 (1993).","journal-title":"J. Exp. Med."},{"key":"1344_CR190","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/337562a0","volume":"337","author":"DA Nemazee","year":"1989","unstructured":"Nemazee, D. A. & B\u00fcrki, K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337, 562\u2013566 (1989).","journal-title":"Nature"},{"key":"1344_CR191","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/ni1256","volume":"6","author":"SB Gauld","year":"2005","unstructured":"Gauld, S. B., Benschop, R. J., Merrell, K. T. & Cambier, J. C. Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling. Nat. Immunol. 6, 1160\u20131167 (2005). This study establishes that peripheral B cell anergy is not a fixed state but an actively maintained programme that requires continuous antigen receptor engagement, with implications for understanding how epigenetic perturbations that alter BCR signalling thresholds can destabilize tolerance without permanently corrupting the underlying chromatin landscape.","journal-title":"Nat. Immunol."},{"key":"1344_CR192","doi-asserted-by":"publisher","first-page":"48009","DOI":"10.1074\/jbc.M200305200","volume":"277","author":"JB Petro","year":"2002","unstructured":"Petro, J. B. et al. Transitional type 1 and 2 B lymphocyte subsets are differentially responsive to antigen receptor signaling. J. Biol. Chem. 277, 48009\u201348019 (2002).","journal-title":"J. Biol. Chem."},{"key":"1344_CR193","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/416865a","volume":"416","author":"A Miyamoto","year":"2002","unstructured":"Miyamoto, A. et al. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase C\u03b4. Nature 416, 865\u2013869 (2002).","journal-title":"Nature"},{"key":"1344_CR194","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1084\/jem.20050630","volume":"202","author":"CM Lau","year":"2005","unstructured":"Lau, C. M. et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor\/Toll-like receptor 7 engagement. J. Exp. Med. 202, 1171\u20131177 (2005).","journal-title":"J. Exp. Med."},{"key":"1344_CR195","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/416603a","volume":"416","author":"EA Leadbetter","year":"2002","unstructured":"Leadbetter, E. A. et al. Chromatin\u2013IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603\u2013607 (2002).","journal-title":"Nature"},{"key":"1344_CR196","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.83908","volume":"12","author":"F Ke","year":"2023","unstructured":"Ke, F. et al. Germinal center B cells that acquire nuclear proteins are specifically suppressed by follicular regulatory T cells. eLife 12, e83908 (2023).","journal-title":"eLife"},{"key":"1344_CR197","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.4049\/jimmunol.1200824","volume":"190","author":"TN Khan","year":"2013","unstructured":"Khan, T. N., Wong, E. B., Soni, C. & Rahman, Z. S. M. Prolonged apoptotic cell accumulation in germinal centers of Mer-deficient mice causes elevated B cell and CD4+ TH cell responses leading to autoantibody production. J. Immunol. 190, 1433\u20131446 (2013).","journal-title":"J. Immunol."},{"key":"1344_CR198","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.immuni.2015.04.010","volume":"42","author":"D Butt","year":"2015","unstructured":"Butt, D. et al. FAS inactivation releases unconventional germinal center B cells that escape antigen control and drive IgE and autoantibody production. Immunity 42, 890\u2013902 (2015).","journal-title":"Immunity"},{"key":"1344_CR199","doi-asserted-by":"publisher","first-page":"E2567","DOI":"10.1073\/pnas.1406974111","volume":"111","author":"Z Sabouri","year":"2014","unstructured":"Sabouri, Z. et al. Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity. Proc. Natl Acad. Sci. USA 111, E2567\u2013E2575 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1344_CR200","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.immuni.2012.07.017","volume":"37","author":"TD Chan","year":"2012","unstructured":"Chan, T. D. et al. Elimination of germinal-center-derived self-reactive B cells is governed by the location and concentration of self-antigen. Immunity 37, 893\u2013904 (2012).","journal-title":"Immunity"},{"key":"1344_CR201","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S1074-7613(03)00323-6","volume":"19","author":"GA Viglianti","year":"2003","unstructured":"Viglianti, G. A. et al. Activation of autoreactive B cells by CpG dsDNA. Immunity 19, 837\u2013847 (2003).","journal-title":"Immunity"},{"key":"1344_CR202","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","volume":"605","author":"GJ Brown","year":"2022","unstructured":"Brown, G. J. et al. TLR7 gain-of-function genetic variation causes human lupus. Nature 605, 349\u2013356 (2022). This study identifies a TLR7 gain-of-function variant in a child with severe lupus that enhances nucleic acid sensing, and demonstrates cell-intrinsic accumulation of CD11c\u207aT-bet\u207aB cells and GC B cells in knock-in mice, indicating that enhanced B cell-intrinsic nucleic acid sensing is sufficient to drive systemic autoimmunity.","journal-title":"Nature"},{"key":"1344_CR203","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.immuni.2008.06.009","volume":"29","author":"RA Herlands","year":"2008","unstructured":"Herlands, R. A., Christensen, S. R., Sweet, R. A., Hershberg, U. & Shlomchik, M. J. T cell-independent and Toll-like receptor-dependent antigen-driven activation of autoreactive B cells. Immunity 29, 249\u2013260 (2008).","journal-title":"Immunity"},{"key":"1344_CR204","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1126\/science.1073924","volume":"297","author":"J William","year":"2002","unstructured":"William, J., Euler, C., Christensen, S. & Shlomchik, M. J. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 297, 2066\u20132070 (2002). This study demonstrates that autoreactive B cells can undergo SHM and affinity maturation through an extrafollicular pathway. This implies that epigenetic defects permitting extrafollicular B cell activation \u2014 without the corrective selection pressures of the GC \u2014 represent a parallel and potentially more permissive route to high-affinity autoantibody production in autoimmune disease.","journal-title":"Science"}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41577-026-01344-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-026-01344-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-026-01344-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:04:01Z","timestamp":1787882641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41577-026-01344-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":204,"alternative-id":["1344"],"URL":"https:\/\/doi.org\/10.1038\/s41577-026-01344-9","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"15 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}